Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TRG-GCC2-6 gene

Known as: TRNAG2, TRG-GCC2-6, transfer RNA-Gly (GCC) 2-6 
 
National Institutes of Health

Related topics

Related topics

1 relation
TRNAG1 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer
Abstract We used American Joint Committee on Cancer (AJCC) Staging Manual system to assess the prognostic significance of tumor… Expand
2014
2014
Tumor Regression Grade of Urothelial Bladder Cancer After Neoadjuvant Chemotherapy: A Novel and Successful Strategy to Predict Survival
Histopathologic tumor regression grades (TRGs) after neoadjuvant chemotherapy predict survival in different cancers. In bladder… Expand
Highly Cited
2011
Highly Cited
2011
Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer.
PURPOSE To assess the prognostic value of the Mandard tumour regression score (TRG) following pre-operative chemo/radiotherapy in… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2010
Highly Cited
2010
Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation.
BACKGROUND AND PURPOSE To explore the utility of tumour regression grading (TRG, the amount of residual tumour cells in relation… Expand
Highly Cited
2009
Highly Cited
2009
Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.
BACKGROUND Preoperative chemoradiation is now standard treatment for stages II-III rectal cancer. Capecitabine (CAP) and… Expand
  • table 2
  • table 3
  • table 1
  • table 4
  • table 5
Highly Cited
2008
Highly Cited
2008
A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy
BackgroundLocally advanced rectal cancer is frequently treated with neoadjuvant chemoradiotherapy to reduce local recurrence and… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2008
2008
Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
OBJECTIVE To determine whether cyclooxygenase-2 (COX-2) expression in pretreatment biopsy specimens is a useful predictive marker… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2006
Highly Cited
2006
Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.
PURPOSE To investigate the effect and feasibility of concurrent radiation and chemotherapy combined with endorectal brachytherapy… Expand
2006
2006
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II study
Oxaliplatin (OXA), raltitrexed (RTX), 5-fluorouracil (FU) and folinic acid (FA) have shown activity in metastatic colorectal… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2002
Highly Cited
2002
Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy
Locally advanced rectal carcinoma has a poor prognosis. However, since the introduction of preoperative radiotherapy, the outcome… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE